(Q35960844)

11 August 2017

1 reference

title

Liver dysfunction and parenteral nutritional therapies (English)

1 reference

11 August 2017

Porayko MK

1

1 reference

11 August 2017

language of work or name

1 reference

1 February 1998

1 reference

11 August 2017

published in

Clinics in liver disease

1 reference

11 August 2017

volume

2

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

133-47, vii

1 reference

Liver Function Tests Abnormalities in Patients with Inflammatory Bowel Disease Receiving Artificial Nutrition: A Prospective Randomized Study of Total Enteral Nutrition vs Total Parenteral Nutrition

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Parenteral drug products containing aluminum as an ingredient or a contaminant: response to Food and Drug Administration notice of intent and request for information. ASCN/A.S.P.E.N. Working Group on Standards for Aluminum Content of Parenteral Nutr

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Small bowel transplantation. A life-saving option for selected patients with intestinal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic complications of total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Changes of Hepatic Morphology During Parenteral Nutrition With Lipid Emulsions Containing LCT or MCT/LCT Quantified by Ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Nutritional care and candidates for small bowel transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Pathogenesis of liver damage during parenteral nutrition: is lipofuscin a clue?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Does long-term home parenteral nutrition in adult patients cause chronic liver disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Liver dysfunction and energy source: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

The effect of total parenteral nutrition on hepatic drug oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Liver function tests in patients receiving parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Parenteral nutrition: short term effects on hepatic clearance of sodium taurocholate and indocyanine green.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Tumor necrosis factor stimulates hepatic lipid synthesis and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Latrogenic lipidosis following prolonged intravenous hyperalimentation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic cytolytic and cholestatic changes related to a change of lipid emulsions in four long-term parenteral nutrition patients with short bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Use of L-glutamine in total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Short bowel syndrome in infancy and childhood. Analysis of survival in 60 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Pathogenesis of hepatic steatosis in the parenterally fed rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Taurine: an essential amino acid to prevent cholestasis in neonates?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

A review of the current national status of home parenteral and enteral nutrition from the provider and consumer perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Four years of North American registry home parenteral nutrition outcome data and their implications for patient management

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Potential candidates for small bowel transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Influence of nutrition on liver oxidative metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat-free parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hyperalimentation-associated jaundice: an example of a serum factor inducing cholestasis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Isolated liver transplantation for liver failure in patients with short bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Review article: practical management of the short bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Liver Function Values in Adults Receiving Total Parenteral Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Clinical and Biological Changes in Liver Function during Intravenous Hyperalimentation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Cyclic hyperalimentation: an optimal technique for preservation of visceral protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

The effect of artificial feeding on cholestasis, gallbladder sludge and lithiasis in infants: correlation with plasma cholecystokinin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Nutritional support of critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Cholestasis associated with total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Chronic liver disease in children on long-term parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatobiliary dysfunction associated with total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Increased risk of cholelithiasis with prolonged total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

The influence of parenteral glutamine and branched-chain amino acids on total parenteral nutrition-induced atrophy of the gut

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Glutamine, parenteral feeding, and intestinal nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatobiliary complications of total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Total parenteral nutrition-induced steatosis: reversal by parenteral lipid infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Essential fatty acid deficiency in four adult patients during total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Intravenous nutrition and hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic complications of total parenteral nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

The effects of light exposure on the in vitro hepatic response to an amino acid-vitamin solution

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic Dysfunction During Hyperalimentation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

1 reference

7 January 2021

The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Morbidity and mortality related to home parenteral nutrition in patients with gut failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Home parenteral nutrition: a review of 100 patient years of treatment in 76 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Abnormal liver function in malnourished patients receiving total parenteral nutrition: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Hepatic secretory obstruction with total parenteral nutrition in the infant

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Morphological fatty changes and function of the liver, serum free fatty acids, and triglycerides during parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

1 reference

7 January 2021

Prevalence of carnitine depletion in critically ill patients with undernutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Experience with home parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Effect of total parenteral nutrition on hepatic histology.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Glucose metabolism in man: responses to intravenous glucose infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Effects of light-exposed parenteral nutrition on hepatic function and lidocaine metabolism: a study using isolated rat liver perfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970368-8

7 January 2021

10.1016/S1089-3261(05)70368-8

Identifiers

DOI

1 reference

release_uvfyhepkibcuvaqnc77xly7gxy

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uvfyhepkibcuvaqnc77xly7gxy

24 November 2022

mapped directly with Wikidata item

1 reference